Tenax Therapeutics, Inc. is a biopharmaceutical company focused on the development of therapies for pulmonary and cardiovascular diseases. The company is engaged in the clinical development of its product candidates, which target conditions such as pulmonary hypertension. Tenax operates primarily in the healthcare sector, serving patients and healthcare providers. Its activities include conducting clinical trials and regulatory submissions to bring new treatments to market.
- Website
- tenaxthera.com
- Issuer profile
- All listings